Outlook Therapeutics, Inc.OTLKNASDAQ
LOADING
|||
Revenue CAGR (5Y)
—
Margin Trend
stable
Free Cash Flow
($51829.4B)
Profitability
Unprofitable
| Metric | Sep 21 | Sep 22 | Sep 23 | Sep 24 | Sep 25 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1,413,535 |
| Gross Profit | -0 | -0↑21.9% | -0↑78.4% | -0↓157.7% | 57,205↑50242065.9% |
| Operating Income | -52 | -63↓21.9% | -53↑15.8% | -72↓35.0% | -67,061,666↓93526901.7% |
| Net Income | -53 | -66↓24.2% | -59↑10.7% | -75↓27.8% | -62,424,863↓82827746.4% |
| EBITDA | -52 | -64↓24.9% | -57↑10.8% | -72↓25.7% | -67,061,666↓93020833.2% |
| EPS Diluted | -6.96 | -6.23↑10.5% | -4.72↑24.2% | -4.06↑14.0% | -1.79↑55.9% |
1 / 2
Values in millions except EPS · Ratios shown as percentages